Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

The development of a semi-structured home interview (CHIF) to directly assess function in cognitively impaired elderly people in two cultures.

Hendrie HC, Lane KA, Ogunniyi A, Baiyewu O, Gureje O, Evans R, Smith-Gamble V, Pettaway M, Unverzagt FW, Gao S, Hall KS.

Int Psychogeriatr. 2006 Dec;18(4):653-66. Epub 2006 Apr 26.

2.

Comorbidity profile of dementia patients in primary care: are they sicker?

Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, Unverzagt F, Hui S, Hendrie HC.

J Am Geriatr Soc. 2006 Jan;54(1):104-9.

PMID:
16420205
3.

Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly.

Hanlon JT, Landerman LR, Artz MB, Gray SL, Fillenbaum GG, Schmader KE.

Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):781-7.

PMID:
15386717
4.

Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force.

Boustani M, Peterson B, Hanson L, Harris R, Lohr KN; U.S. Preventive Services Task Force.

Ann Intern Med. 2003 Jun 3;138(11):927-37. Review.

PMID:
12779304
5.

Who is using chronic acid suppression therapy and why?

Jacobson BC, Ferris TG, Shea TL, Mahlis EM, Lee TH, Wang TC.

Am J Gastroenterol. 2003 Jan;98(1):51-8.

PMID:
12526936
6.

Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.

Wolff JL, Starfield B, Anderson G.

Arch Intern Med. 2002 Nov 11;162(20):2269-76.

PMID:
12418941
7.

Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans.

Murray MD, Lane KA, Gao S, Evans RM, Unverzagt FW, Hall KS, Hendrie H.

Arch Intern Med. 2002 Oct 14;162(18):2090-6.

PMID:
12374517
8.

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study.

Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC; Cache County Study Investigators.

Neurology. 2002 Sep 24;59(6):880-6.

PMID:
12297571
9.

Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.

Ruscin JM, Page RL 2nd, Valuck RJ.

Ann Pharmacother. 2002 May;36(5):812-6.

PMID:
11978157
10.

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances.

Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S.

Annu Rev Public Health. 2002;23:213-31. Epub 2001 Oct 25. Review.

PMID:
11910061
11.

H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine.

Carlson MC, Tschanz JT, Norton MC, Welsh-Bohmer K, Martin BK, Breitner JC.

Alzheimer Dis Assoc Disord. 2002 Jan-Mar;16(1):24-30.

PMID:
11882746
12.

Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging.

Unverzagt FW, Gao S, Baiyewu O, Ogunniyi AO, Gureje O, Perkins A, Emsley CL, Dickens J, Evans R, Musick B, Hall KS, Hui SL, Hendrie HC.

Neurology. 2001 Nov 13;57(9):1655-62.

PMID:
11706107
13.

Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.

Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, Gao S, Evans RM, Ogunseyinde AO, Adeyinka AO, Musick B, Hui SL.

JAMA. 2001 Feb 14;285(6):739-47.

PMID:
11176911
14.

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study.

Anthony JC, Breitner JC, Zandi PP, Meyer MR, Jurasova I, Norton MC, Stone SV.

Neurology. 2000 Jun 13;54(11):2066-71.

PMID:
10851364
15.

Drug-induced cognitive impairment in the elderly.

Moore AR, O'Keeffe ST.

Drugs Aging. 1999 Jul;15(1):15-28. Review.

PMID:
10459729
16.

Histamine H2 blocking drugs and the risk for Alzheimer's disease: the Rotterdam Study.

Launer LJ, Jama JW, Ott A, Breteler MM, Hoes AW, Hofman A.

Neurobiol Aging. 1997 Mar-Apr;18(2):257-9.

PMID:
9258905
17.

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM.

Neurobiol Aging. 1995 Jul-Aug;16(4):523-30.

PMID:
8544901
18.

Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans.

Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW, Gureje O, Rodenberg CA, Baiyewu O, Musick BS.

Am J Psychiatry. 1995 Oct;152(10):1485-92.

PMID:
7573588
19.
20.

Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease.

Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A.

Psychopharmacol Bull. 1988;24(4):641-52. No abstract available.

PMID:
3249766

Supplemental Content

Support Center